Innovation doesn't happen in isolation. The Baker Institute partners with pharmaceutical companies, biotech firms, medical device developers and health technology businesses to bring life-changing discoveries closer to the people who need them.
With a century of scientific leadership behind us and a clear focus on what's ahead, we offer industry partners a direct route from promising research to real-world application.
What we offer
When you partner with the Baker Institute, you gain access to:
- World-class research expertise in cardiovascular disease, diabetes and metabolic health — spanning discovery, translational and clinical research.
- State-of-the-art facilities including advanced imaging, biomedical engineering capabilities and data analytics infrastructure.
- Direct access to clinical environments and diverse patient cohorts through our Alfred Health partnership.
- Clinician-researcher talent for co-designed programs built around real clinical challenges.
- Clear commercialisation pathways including licensing, joint development, spin-outs and industry-sponsored research.
- Opportunities to align with government-funded initiatives and leverage non-dilutive funding.
Research and innovation focus of our core programs:
- cardiovascular disease
- heart failure
- diabetes
- metabolic health
- coronary artery disease
- arrhythmia
- advanced imaging
- digital health
- medical devices
- biomedical engineering
- population health and prevention.
How it works
Getting started is straightforward. Reach out to our Innovation and Commercialisation team to discuss your objectives. We'll explore partnership models suited to your needs — research, translational or commercial — and co-design an engagement approach supported by clear IP and governance frameworks.